Page last updated: 2024-08-18

pyrroles and Experimental Neoplasms

pyrroles has been researched along with Experimental Neoplasms in 101 studies

Research

Studies (101)

TimeframeStudies, this research(%)All Research%
pre-199017 (16.83)18.7374
1990's5 (4.95)18.2507
2000's24 (23.76)29.6817
2010's48 (47.52)24.3611
2020's7 (6.93)2.80

Authors

AuthorsStudies
Feng, Z; Gao, C; He, H; Li, X; Liu, Z; Ran, K; Shi, Y; Wang, N; Wei, W; Ye, T; Yu, L; Zhu, Y1
Ding, L; Huang, T; Jiang, H; Liang, Y; Liu, Y; Sattar, S; Shang, Y; Wang, M; Wei, Y; Wu, B; Yang, T; Zhang, D; Zhou, F1
Cong, L; Dong, J; Ke, M; Li, Y; Lv, Y; Wang, X; Zhang, Z; Zhao, S; Zhu, Y1
Geng, S; Yang, X; Zhan, G; Zhao, H; Zhao, Y1
Andreeva, DV; Dezhenkova, LG; Kaluzhny, DN; Litvinova, VA; Moisenovich, MM; Ramonova, AA; Schols, D; Shchekotikhin, AE; Shtil, AA; Tikhomirov, AS; Treshalin, ID; Tsvetkov, VB; Volodina, YL1
Chen, Z; Fan, Q; Hu, X; Li, T; Zhang, R; Zheng, Z1
Deng, Q; Huang, Y; Jin, X; Liu, Z; Qing, W; Xing, X1
Bouakaz, A; Chen, J; Feng, Y; Qin, D; Wan, M; Wu, D; Zhang, L; Zhu, H1
Cheng, B; Cheng, Y; Ding, Z; Fang, L; Li, H; Li, M; Li, Y; Lin, X; Liu, K; Lu, D; Shao, X; Shi, W; Su, W; Wu, C; Zhang, J1
Agalou, A; Argyros, O; Asvos, X; Beis, D; Davos, CH; Fokas, D; Karampelas, T; Papakyriakou, A; Tamvakopoulos, C; Varela, A1
Alon, L; Bar-Shir, A; Bulte, JWM; Gilad, AA; Kato, Y; Korrer, MJ; Lim, HS; Pathak, AP; Yadav, NN1
Bao, Y; Cao, Y; Huang, Y; Li, Y; Liu, L; Sun, L; Yang, X; Yi, J; Yu, C1
Beauvineau, C; Busser, B; Coll, JL; Falson, P; Fernando Díaz, J; Frachet, V; Gilson, P; Hurbin, A; Josa-Prado, F; Lafanechère, L; Mahuteau-Betzer, F; Moreno, A; Naud-Martin, D; Vanwonterghem, L1
Dong, X; Liang, P; Si, W; Wang, P; Wang, Y; Xu, H; Zhang, Y; Zou, J1
Cao, H; Gao, Y; Jiang, X; Liu, Y; Qu, Z; Sun, H1
Xie, Z; Zhang, T; Zhang, W; Zheng, M1
Cai, C; Hu, Y; Lu, S; Peng, C; Popovtzer, R; Shen, M; Shi, X; Sun, W; Yu, J; Zhou, Y1
Jin, Y; Tian, J; Yang, X1
He, H; Liu, S; Shuai, X; Wang, Y; Xie, Z; Yu, M; Zheng, M; Zheng, X1
Cao, Y; Guo, Y; Kang, Y; Li, CM; Li, W; Liu, H; Lu, SY; Ran, HT; Wang, J; Wang, X; Wang, ZG1
Morton, D; Nambiar, PR1
Behrendt, FF; Bzyl, J; Mottaghy, FM; Palmowski, K; Palmowski, M; Rix, A; Verburg, FA; Winz, O1
Banerjee, S; Baral, R; Barik, S; Bhuniya, A; Bose, A; Das, A; Ghosh, S; Ghosh, T; Pal, S; Paul, T; Roy, S; Sarkar, M1
Dai, Z; Jin, Y; Qu, E; Wang, J; Wang, S; Zha, Z; Zhang, S1
Bremer, C; Budny, T; Hahnenkamp, A; Heindel, W; Persigehl, T; Remmele, S; Ring, J; Schwartz, LH; Spiegel, HU; Stoeppeler, S1
Beraldi, E; Crafter, C; Davies, BR; Fazli, L; Gleave, ME; Kim, S; Lamoureux, F; Thaper, D; Thomas, C; Zoubeidi, A1
Blackwood, E; Del Nagro, C; Evangelista, M; Jackson, PK; Kowanetz, K; Malek, S; O'Brien, T; Ramiscal, J; Xiao, Y1
Dai, Z; Qu, E; Wang, J; Wang, S; Zha, Z; Zhang, S; Zhang, Y1
Behrendt, FF; Gray, BD; Kiessling, F; Lederle, W; Mottaghy, FM; Pak, KY; Palmowski, K; Palmowski, M; Rix, A1
Awad, GA; El-Safoury, DM; Motaleb, MA; Sakr, TM1
Dong, Z; Imai, A; Krishnamurthy, S; Nör, JE; Zeitlin, BD; Zhang, Z1
Bize, PE; Borchard, G; Denys, A; Doelker, E; Dormond, O; Fuchs, K; Jordan, O1
Conney, AH; Cui, XX; Ding, N; Du, Z; Gao, Z; Hu, C; Huang, H; Lin, Y; Rabson, AB; Shih, WJ; Wei, X; Zheng, X1
Bernhardt, A; Fallon, J; Greiner, JW; Guzman, W; Kradjian, G; Lan, Y; Neuteboom, B; Sabzevari, H; Schlom, J; Tighe, R1
Fan, C; Gong, X; Yang, Y; Zhang, L; Zhao, S; Zheng, Q; Zhou, H1
Arlot-Bonnemains, Y; Belaud-Rotureau, MA; Bensalah, K; Collet, N; Dolley-Hitze, T; Jouan, F; Lavenu, A; Oger, E; Rioux-Leclercq, N; Verhoest, G; Vigneau, C1
Avanzi, N; Ballinari, D; Bandiera, T; Bertrand, J; Bindi, S; Brasca, MG; Canevari, G; Carenzi, D; Casero, D; Ceriani, L; Ciomei, M; Cirla, A; Colombo, M; Cribioli, S; Cristiani, C; Della Vedova, F; Donati, D; Fachin, G; Fasolini, M; Felder, ER; Galvani, A; Gnocchi, P; Isacchi, A; Mirizzi, D; Motto, I; Nesi, M; Panzeri, A; Pesenti, E; Vianello, P1
Coplin, MA; Donahue, RN; Farsaci, B; Grenga, I; Hodge, JW; Lepone, LM; Molinolo, AA1
Balansky, R; D'Agostini, F; De Flora, S; Ganchev, G; Iltcheva, M; La Maestra, S; Micale, RT; Nikolov, M; Steele, VE1
Baldini, C; Bridal, SL; Comperat, E; Dizeux, A; Lamuraglia, M; Le Guillou-Buffello, D; Lucidarme, O; Payen, T1
Taieb, J; Tartour, É; Terme, M; Voron, T1
Choi, EK; Jeong, SY; Kim, J; Kim, N; Koo, HJ; Lee, JS; Lee, M; Woo, CW1
Boos, A; Chen, B; Fairhurst, RA; Furet, P; Guagnano, V; Jeay, S; Jiang, S; Lu, W; Marsilje, TH; McCarthy, C; Michellys, PY; Niklaus, M; Schnell, C; Stauffer, F; Stutz, S; Vaupel, A1
Andrews, KL; Booker, SK; Cee, VJ; Chavez, F; Chen, J; Chen, Y; Eastwood, H; Guerrero, N; Herberich, B; Hickman, D; Lanman, BA; Laszlo, J; Lee, MR; Lipford, JR; Mattson, B; Mohr, C; Nguyen, Y; Norman, MH; Pettus, LH; Powers, D; Reed, AB; Rex, K; Sastri, C; Tamayo, N; Tasker, AS; Wang, HL; Wang, P; Winston, JT; Wu, B; Wu, T; Wurz, RP; Xu, Y; Zhou, Y1
Arosio, D; Battistini, L; Bianchini, F; Calorini, L; Portioli, E; Pupi, A; Sartori, A; Vacondio, F; Zanardi, F1
Guan, XY; Huang, XR; Lan, HY; Li, CJ; Lian, GY; Meng, XM; Tang, PM; Tang, YJ; To, KF; Wang, QM; Yan, BP; Zhou, S1
Angeles, TS; Mallamo, JP; Tripathy, R; Yang, SX1
Ajith, TA; Anu, V; Riji, T1
Dabora, SL; Lee, N; Messina, MP; Nobil, AM; Rauktys, AE; Woodrum, CL1
Arregi, A; Azpiroz, A; Beitia, G; Garmendia, L; Vegas, O1
Suddek, GM1
Christensen, JG; Esparza, CO; Feng, J; Hu-Lowe, DD; Lee, JH; Plumlee, PA; Shojaei, F; Simmons, BH; Stewart, AE; Wong, A1
Jiao, XD; Li, R; Su, B; Takayama, K; Wang, JJ; Zhang, HP1
Farsaci, B; Higgins, JP; Hodge, JW1
Belisario, DC; Bolli, E; Bosia, A; Calogero, RA; Cavallo, F; Pinto, H; Riganti, C1
Calcinaro, F; D'Agostino, M; Durante, C; Filetti, S; Moretti, S; Puxeddu, E; Rhoden, K; Russo, D; Sponziello, M; Tallini, G; Tamburrano, G; Voce, P1
Berman, JN; Colpitts, J; Corkery, DP; Dellaire, G; Forrester, AM; McFarland, SA; Smithen, DA; Thompson, A1
Dai, Z; Ren, Q; Yue, X; Zha, Z1
Czarnota, GJ; El Kaffas, A; Giles, A1
Baker, CH; Bucana, CD; Fidler, IJ; Kedar, D; McCarty, MF; Tsan, R; Weber, KL1
Gallo, JM; Guo, P; Li, S; Ma, J; Reed, K1
Donnelly, E; Geng, L; Hallahan, DE; Himmelfarb, E; McMahon, G; Mendel, D; Schueneman, AJ; Tan, J1
Bäckman, U; Christofferson, R; Svensson, A1
LEPESHKINA, GN; ROSSOLIMO, OK; STANISLAVSKAIA, MS1
FINGER, H; FRETZDORFF, AM; SCHNEIDER, F; SEYNSCHE, K; WEITZEL, G1
CAMPBELL, GW; DULANEY, EL; GITTERMAN, CO; HENDLIN, D; KACZKA, EA; WOODRUFF, HB1
MAN'KO, IV; PETROVA, MF; PUKHAL'SKAIA, ACh1
French, KJ; Lee, BD; Smith, CD; Zhuang, Y1
Engel, JB; Halmos, G; Hammann, B; Keller, G; Nagy, A; Schally, AV1
Fu, M; Guo, S; Li, S; Liang, X; Lin, C; Lu, H; Wu, M; Zhang, X; Zheng, Z1
Chowbay, B; Lye, KY; Moore, S; Olivo, M; Sharma, A; Zhou, Q1
Garcia-Echeverria, C1
Jiang, XT; Tao, HQ; Zou, SC1
Bibby, MC; Burger, AM; Fiebig, HH; Loadman, PM; Schultz, R; Thurston, DE1
Boschi, F; D'Onofrio, M; Faccioli, N; Marzola, P; Pozzi Mucelli, R; Sbarbati, A1
Alaoui-Jamali, MA; Chen, G; Hu, K; Li, B; Li, J; Lyle, MP; Tang, L; Webster, J1
Alexander, HR; Blansfield, JA; Caragacianu, D; Libutti, SK; Lorang, D; Morita, SY; Muller, G; Royal, RE; Schafer, P; Stirling, D; Tangrea, MA1
Courtright, J; Houghton, PJ; Keir, ST; Kolb, EA; Lock, R; Maris, JM; Morton, CL; Reynolds, CP; Smith, MA; Tajbakhsh, M; Wu, J1
Anderson, WK1
Anderson, WK; McPherson, HL; New, JS; Rick, AC1
Anderson, WK; Chang, CP; Corey, PF; Halat, MJ; Jones, AN; McPherson, HL; New, JS; Rich, AC1
Higuchi, S; Saito, K; Sakamoto, Y; Yamaguchi, T; Yosida, S; Yuki, H1
App, H; Fong, TA; Hirth, KP; Kim, YH; McMahon, G; Powell, TJ; Risau, W; Schreck, R; Shawver, LK; Sun, L; Tang, C; Ullrich, A; Wang, X1
Arakawa, H; Kawamoto, H; Kojiri, K; Kondo, H; Morishima, H; Nishimura, I; Nishimura, S; Nishimura, T; Ohkubo, M; Suda, H; Tanaka, S; Yoshinari, T1
Andoh, T; Edatsugi, H; Ishizu, K; Kohno, H; Komatsu, H; Komi, A; Matsuba, Y; Matsunaga, A; Mita, I; Nakajima, Y; Nakanishi, O; Sato, S; Takezawa, K; Tsuruo, T; Yamazaki, K; Yamori, T1
Blake, RA; Fong, TA; Hawtin, R; Hirth, KP; Hubbard, SR; Laird, AD; Liang, C; McMahon, G; Mohammadi, M; Schlessinger, J; Shawver, LK; Shenoy, N; Strawn, LM; Sun, L; Tang, C; Tang, F; Thurnher, A; Ullrich, A; Vajkoczy, P1
Amishiro, N; Gomi, K; Kobayashi, E; Nagamura, S; Okabe, M; Okamoto, A; Saito, H1
Csernus, B; Halmos, G; Hebert, F; Nagy, A; Schally, AV; Sun, B; Szepeshazi, K1
Halmos, G; Nagy, A; Plonowski, A; Schally, AV; Sun, B1
Carver, J; Cherrington, JM; Christensen, JG; Laird, AD; Li, G; Louie, SG; Mendel, DB; Moss, KG; Smith, K; Xin, X1
Biaglow, JE; Chapman, JD; Durand, RE; Raleigh, JA; Rauth, AM; Reuvers, AP1
Cabral, JR; Mattocks, AR1
Sydor, A1
Herzfeld, A; Knox, WE; Mezl, VA1
Dominick, MA; McGuire, EJ; Sigler, RE1
Braune, M; Freyer, W; Lewald, T; Naether, D; Nowak, C; Roeder, B1
Pitot, HC; Weiss, JW1
Muzik, H; Paterson, AR; Warnick, CT1
Gitterman, CO1
Artico, M; Dolfini, E; Giuliano, R; Morasca, L; Porretta, GC; Scalzo, M; Vomero, S1
Balitskiĭ, KP; Struk, VI1

Trials

1 trial(s) available for pyrroles and Experimental Neoplasms

ArticleYear
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:6

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Anthracenes; Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Screening Assays, Antitumor; Gene Expression; Indoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Oxindoles; Perylene; Photochemotherapy; Propionates; Protein-Tyrosine Kinases; Proteins; Pyrroles; Survival Rate

2005

Other Studies

100 other study(ies) available for pyrroles and Experimental Neoplasms

ArticleYear
Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancer.
    European journal of medicinal chemistry, 2022, Jan-15, Volume: 228

    Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Focal Adhesion Kinase 1; Humans; Indans; Mice; Mice, Inbred BALB C; Mice, Nude; Microsomes, Liver; Molecular Structure; Neoplasms, Experimental; Ovarian Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Structure-Activity Relationship; Tumor Cells, Cultured

2022
TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway.
    Aging, 2019, 10-19, Volume: 11, Issue:20

    Topics: Animals; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Neoplasms, Experimental; Pyrazoles; Pyrroles; Radiation Tolerance; Signal Transduction; Smad4 Protein; Stomach Neoplasms; Transforming Growth Factor beta

2019
MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 120

    Topics: Aminopyridines; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Nude; MicroRNAs; Neoplasm Metastasis; Neoplasms, Experimental; Pyrroles; Signal Transduction

2019
Injectable in Situ Forming Hydrogels of Thermosensitive Polypyrrole Nanoplatforms for Precisely Synergistic Photothermo-Chemotherapy.
    ACS applied materials & interfaces, 2020, Feb-19, Volume: 12, Issue:7

    Topics: Acrylic Resins; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Combined Modality Therapy; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Drug Liberation; Humans; Hydrogels; Hyperthermia, Induced; Infrared Rays; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanogels; Neoplasms, Experimental; NIH 3T3 Cells; Phase Transition; Phototherapy; Polymers; Pyrroles; Temperature; Xenograft Model Antitumor Assays

2020
Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
    European journal of medicinal chemistry, 2020, Aug-01, Volume: 199

    Topics: Amides; Animals; Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; K562 Cells; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Docking Simulation; Molecular Structure; Neoplasms, Experimental; Pyrroles; Structure-Activity Relationship; Thiophenes

2020
The Novel DPP-BDT Nanoparticles as Efficient Photoacoustic Imaging and Positron Emission Tomography Agents in Living Mice.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Animals; Contrast Media; Copper Radioisotopes; Female; Hep G2 Cells; Humans; Injections; Ketones; Mice; Mice, Nude; Multimodal Imaging; Nanoparticles; Neoplasms, Experimental; NIH 3T3 Cells; Phosphatidylethanolamines; Photoacoustic Techniques; Polyethylene Glycols; Polymers; Positron-Emission Tomography; Pyrroles; Radiopharmaceuticals; Xenograft Model Antitumor Assays

2020
Molecular engineering of diketopyrrolopyrrole-conjugated polymer nanoparticles by chalcogenide variation for photoacoustic imaging guided photothermal therapy.
    Journal of materials chemistry. B, 2021, 04-14, Volume: 9, Issue:14

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcogens; Drug Screening Assays, Antitumor; Humans; Ketones; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Photoacoustic Techniques; Photothermal Therapy; Polymers; Pyrroles

2021
A Highly Efficient One-for-All Nanodroplet for Ultrasound Imaging-Guided and Cavitation-Enhanced Photothermal Therapy.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Animals; Contrast Media; Female; Fluorocarbons; HeLa Cells; Humans; Mice, Inbred BALB C; Microbubbles; Nanostructures; Neoplasms; Neoplasms, Experimental; Phase Transition; Photoacoustic Techniques; Photothermal Therapy; Polymers; Pyrroles; Ultrasonography; Xenograft Model Antitumor Assays

2021
A novel pyrrole-imidazole polyamide targets Aurora kinase A and suppresses tumor growth in vivo.
    Biochemical and biophysical research communications, 2021, 09-24, Volume: 571

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Nylons; Protein Kinase Inhibitors; Pyrroles; Tumor Cells, Cultured

2021
Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.
    Oncotarget, 2017, Jun-06, Volume: 8, Issue:23

    Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasms, Experimental; Oxindoles; Pyrroles; Sunitinib; Tumor Burden; Tumor Microenvironment; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2017
Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy.
    Magnetic resonance in medicine, 2018, Volume: 79, Issue:2

    Topics: Animals; Biomedical Research; Brain Neoplasms; Cell Tracking; Dendritic Cells; Deoxycytidine; Drosophila melanogaster; Flow Cytometry; Genes, Insect; Genes, Reporter; Genetic Engineering; HEK293 Cells; Humans; Immunotherapy; Magnetic Resonance Imaging; Neoplasms, Experimental; Phosphotransferases (Alcohol Group Acceptor); Pyrroles

2018
Efficient Cancer Regression by a Thermosensitive Liposome for Photoacoustic Imaging-Guided Photothermal/Chemo Combinatorial Therapy.
    Biomacromolecules, 2017, Aug-14, Volume: 18, Issue:8

    Topics: Animals; Hep G2 Cells; Humans; Hypothermia, Induced; Ketones; Liposomes; Mice; Neoplasms, Experimental; Photoacoustic Techniques; Phototherapy; Polyethylene Glycols; Pyrroles; Xenograft Model Antitumor Assays

2017
Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.
    Scientific reports, 2017, 08-31, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chick Embryo; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Neoplasms, Experimental; Pyrimidines; Pyrroles; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays

2017
Triphenylamine flanked furan-diketopyrrolopyrrole for multi-imaging guided photothermal/photodynamic cancer therapy.
    Nanoscale, 2017, Dec-07, Volume: 9, Issue:47

    Topics: Animals; Furans; HeLa Cells; Humans; Ketones; Mice; Nanoparticles; Neoplasms, Experimental; Photochemotherapy; Phototherapy; Pyrroles

2017
pH Switchable Nanoassembly for Imaging a Broad Range of Malignant Tumors.
    ACS nano, 2017, 12-26, Volume: 11, Issue:12

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cells, Cultured; Drug Screening Assays, Antitumor; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Ketones; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Neoplasms, Experimental; Pyrroles; Thiophenes; Tumor Microenvironment

2017
Near-infrared BODIPY-paclitaxel conjugates assembling organic nanoparticles for chemotherapy and bioimaging.
    Journal of colloid and interface science, 2018, Mar-15, Volume: 514

    Topics: Animals; Antineoplastic Agents, Phytogenic; Boron Compounds; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Fluorescent Dyes; Halogenation; Humans; Infrared Rays; Mice; Mice, Inbred Strains; Nanoparticles; Neoplasms, Experimental; Optical Imaging; Paclitaxel; Particle Size; Pyrroles; Surface Properties; Tumor Cells, Cultured

2018
Radiotherapy-Sensitized Tumor Photothermal Ablation Using γ-Polyglutamic Acid Nanogels Loaded with Polypyrrole.
    Biomacromolecules, 2018, 06-11, Volume: 19, Issue:6

    Topics: Animals; Female; Gels; Mice; Mice, Inbred BALB C; Nanostructures; Neoplasms, Experimental; Photoacoustic Techniques; Photochemotherapy; Polyglutamic Acid; Polymerization; Polymers; Pyrroles; Radiotherapy; X-Rays; Xenograft Model Antitumor Assays

2018
Targeted polypyrrole nanoparticles for the identification and treatment of hepatocellular carcinoma.
    Nanoscale, 2018, May-24, Volume: 10, Issue:20

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms, Experimental; Optical Imaging; Phototherapy; Polymers; Pyrroles; Theranostic Nanomedicine

2018
Diketopyrrolopyrrole-based carbon dots for photodynamic therapy.
    Nanoscale, 2018, Jun-14, Volume: 10, Issue:23

    Topics: Animals; Carbon; Chitosan; Female; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Ketones; Mice; Neoplasms, Experimental; Photochemotherapy; Pyrroles; Quantum Dots; Xenograft Model Antitumor Assays

2018
Enhanced Photoacoustic and Photothermal Effect of Functionalized Polypyrrole Nanoparticles for Near-Infrared Theranostic Treatment of Tumor.
    Biomacromolecules, 2019, 01-14, Volume: 20, Issue:1

    Topics: Animals; HeLa Cells; Humans; Hyperthermia, Induced; Indocyanine Green; Indoles; Infrared Rays; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Photoacoustic Techniques; Phototherapy; Polyethylene Glycols; Polymers; Pyrroles

2019
The rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals.
    Toxicologic pathology, 2013, Volume: 41, Issue:8

    Topics: Animals; Body Weight; Carcinogenicity Tests; Cell Proliferation; Female; Genes, ras; Indoles; Male; Mice; Mice, Transgenic; Models, Animal; Neoplasms, Experimental; Pyrroles; Rats; Rats, Sprague-Dawley; Sunitinib

2013
Accuracy of a clinical PET/CT vs. a preclinical μPET system for monitoring treatment effects in tumour xenografts.
    European journal of radiology, 2013, Volume: 82, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Monitoring; Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Indoles; Mice; Mice, Nude; Multimodal Imaging; Neoplasms, Experimental; Positron-Emission Tomography; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome

2013
Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment.
    International immunopharmacology, 2013, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Azadirachta; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cisplatin; Cytokines; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Indoles; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Plant Leaves; Pyrroles; Sunitinib

2013
Polypyrrole hollow microspheres as echogenic photothermal agent for ultrasound imaging guided tumor ablation.
    Scientific reports, 2013, Volume: 3

    Topics: Animals; Cell Line, Tumor; Contrast Media; Humans; Microspheres; Neoplasms, Experimental; Photosensitizing Agents; Phototherapy; Polymers; Pyrroles; Rabbits; Treatment Outcome; Ultrasonography, Interventional

2013
Vessel size imaging (VSI) by robust magnetic resonance (MR) relaxometry: MR-VSI of solid tumors in correlation with immunohistology and intravital microscopy.
    Molecular imaging, 2013, Volume: 12, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Dextrans; Female; Humans; Immunohistochemistry; Indoles; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, Nude; Microscopy; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Pyrroles; Random Allocation; Sunitinib

2013
Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivo.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:11

    Topics: Androgen Receptor Antagonists; Anilides; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Disease Progression; Drug Therapy, Combination; Humans; Male; Mice; Mice, Nude; Neoplasms, Experimental; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Receptors, Androgen; Signal Transduction; Tosyl Compounds; Xenograft Model Antitumor Assays

2013
Identification of preferred chemotherapeutics for combining with a CHK1 inhibitor.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:11

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbolines; Cell Cycle Checkpoints; Checkpoint Kinase 1; Dacarbazine; Deoxycytidine; DNA Damage; Gemcitabine; HCT116 Cells; High-Throughput Nucleotide Sequencing; HT29 Cells; Humans; Irinotecan; Mice; Mice, Nude; Neoplasms; Neoplasms, Experimental; Protein Kinase Inhibitors; Protein Kinases; Pyridines; Pyrroles; Temozolomide; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2013
Engineering of perfluorooctylbromide polypyrrole nano-/microcapsules for simultaneous contrast enhanced ultrasound imaging and photothermal treatment of cancer.
    Biomaterials, 2014, Volume: 35, Issue:1

    Topics: Animals; Cells, Cultured; Female; Fluorocarbons; Humans; Hydrocarbons, Brominated; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Neoplasms, Experimental; Particle Size; Phototherapy; Polymers; Pyrroles; Ultrasonography

2014
A low molecular weight zinc2+-dipicolylamine-based probe detects apoptosis during tumour treatment better than an annexin V-based probe.
    European radiology, 2014, Volume: 24, Issue:2

    Topics: Amines; Angiogenesis Inhibitors; Animals; Annexin A5; Apoptosis; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Indoles; Mice; Mice, Nude; Molecular Probes; Molecular Weight; Neoplasms, Experimental; Organometallic Compounds; Picolinic Acids; Pyrroles; Skin Neoplasms; Sunitinib; Tumor Cells, Cultured; Zinc

2014
Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging.
    Journal of labelled compounds & radiopharmaceuticals, 2013, Jun-30, Volume: 56, Issue:8

    Topics: Animals; Cell Hypoxia; Indoles; Isotope Labeling; Mice; Neoplasms, Experimental; Organotechnetium Compounds; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, Emission-Computed, Single-Photon

2013
Xenograft tumors vascularized with murine blood vessels may overestimate the effect of anti-tumor drugs: a pilot study.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Animals; Blood Vessels; Cell Proliferation; Cisplatin; Endothelial Cells; Heterografts; Humans; Indoles; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pilot Projects; Pyrroles; Signal Transduction; Species Specificity; Sunitinib; Tissue Engineering; Tumor Microenvironment

2013
Drug-eluting beads loaded with antiangiogenic agents for chemoembolization: in vitro sunitinib loading and release and in vivo pharmacokinetics in an animal model.
    Journal of vascular and interventional radiology : JVIR, 2014, Volume: 25, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Survival; Chemoembolization, Therapeutic; Delayed-Action Preparations; Drug-Eluting Stents; Indoles; Metabolic Clearance Rate; Microspheres; Neoplasms, Experimental; Organ Specificity; Pyrroles; Rabbits; Sunitinib; Tissue Distribution

2014
A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.
    International journal of oncology, 2014, Volume: 44, Issue:6

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Atorvastatin; Celecoxib; Cell Line, Tumor; Cell Proliferation; Female; Heptanoic Acids; Humans; Injections, Intraperitoneal; Mice; Mice, SCID; Neoplasms, Experimental; Pancreatic Neoplasms; Pyrazoles; Pyrroles; Quinolones; Sulfonamides; Xenograft Model Antitumor Assays

2014
The immunocytokine NHS-IL12 as a potential cancer therapeutic.
    Oncotarget, 2014, Apr-15, Volume: 5, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Docetaxel; Female; Humans; Immunoglobulin G; Immunomodulation; Indoles; Interferon-gamma; Interleukin-12; Lymphocyte Activation; Macaca fascicularis; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms, Experimental; Protein Engineering; Pyrroles; Recombinant Fusion Proteins; Sunitinib; Survival Rate; Taxoids; Tumor Burden

2014
Synthesis and in vivo SAR study of indolin-2-one-based multi-targeted inhibitors as potential anticancer agents.
    European journal of medicinal chemistry, 2014, Jul-23, Volume: 82

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Indoles; Mice; Molecular Structure; Neoplasms, Experimental; Protein Kinase Inhibitors; Protein Kinases; Pyrroles; Structure-Activity Relationship; Sunitinib

2014
Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.
    BioMed research international, 2014, Volume: 2014

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Benzoates; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Pyrroles; Sunitinib; Telmisartan; Xenograft Model Antitumor Assays

2014
Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.
    Bioorganic & medicinal chemistry, 2014, Sep-01, Volume: 22, Issue:17

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Janus Kinase 2; Mice; Mice, SCID; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Structure-Activity Relationship; Substrate Specificity

2014
Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.
    Cancer immunology research, 2014, Volume: 2, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Cancer Vaccines; Cell Line, Tumor; Combined Modality Therapy; Female; Flow Cytometry; Humans; Indoles; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Experimental; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Sorafenib; Sunitinib; Vaccines, Synthetic

2014
Modulation by licofelone and celecoxib of experimentally induced cancer and preneoplastic lesions in mice exposed to cigarette smoke.
    Current cancer drug targets, 2015, Volume: 15, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Body Weight; Celecoxib; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Female; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Precancerous Conditions; Pyrroles; Smoking; Survival Rate; Toxicity Tests, Subchronic

2015
VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Ultrasound in medicine & biology, 2015, Volume: 41, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Survival; Contrast Media; Drug Monitoring; Female; Imatinib Mesylate; Indoles; Mice; Mice, Inbred BALB C; Molecular Imaging; Neoplasms, Experimental; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Sunitinib; Treatment Outcome; Ultrasonography; Vascular Endothelial Growth Factor Receptor-2

2015
[Impact of VEGF-A in exhaustion of intratumoral T cells].
    Medecine sciences : M/S, 2015, Volume: 31, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Gene Expression Regulation, Neoplastic; Humans; Indoles; Lymphocytes, Tumor-Infiltrating; Molecular Targeted Therapy; Neoplasm Proteins; Neoplasms, Experimental; Programmed Cell Death 1 Receptor; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sunitinib; T-Lymphocytes, Cytotoxic; Vascular Endothelial Growth Factor A

2015
Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Combined Modality Therapy; Contrast Media; Gadolinium DTPA; Humans; Indoles; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Muscle, Skeletal; Neoplasms, Experimental; Pyrroles; Random Allocation; Sunitinib; Thigh; Transplantation, Heterotopic; Tumor Burden; Xenograft Model Antitumor Assays

2016
Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors.
    Bioorganic & medicinal chemistry letters, 2016, Apr-15, Volume: 26, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Imidazoles; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; NIH 3T3 Cells; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2016
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors.
    Journal of medicinal chemistry, 2016, 07-14, Volume: 59, Issue:13

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Humans; Mice; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyrroles; Quinazolinones; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2016
Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the α
    Journal of medicinal chemistry, 2017, 01-12, Volume: 60, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Cell Line; Humans; Indoles; Integrin alphaVbeta3; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Oligopeptides; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor Receptor-2

2017
Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.
    Nature communications, 2017, 03-06, Volume: 8

    Topics: Animals; Basic-Leucine Zipper Transcription Factors; Cell Differentiation; Cell Line, Tumor; Disease Progression; Female; Isoquinolines; Kaplan-Meier Estimate; Killer Cells, Natural; Male; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mice, Transgenic; Neoplasms, Experimental; Pyridines; Pyrroles; RNA Interference; Smad3 Protein

2017
TrkA kinase inhibitors from a library of modified and isosteric Staurosporine aglycone.
    Bioorganic & medicinal chemistry letters, 2008, Jun-15, Volume: 18, Issue:12

    Topics: Animals; Antineoplastic Agents; Carbazoles; Male; Molecular Conformation; Neoplasms, Experimental; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, trkA; Small Molecule Libraries; Staurosporine; Stereoisomerism; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2008
Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
    Journal of experimental therapeutics & oncology, 2008, Volume: 7, Issue:4

    Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Atorvastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Mice; Models, Chemical; Neoplasms, Experimental; Pyrroles; Reactive Oxygen Species

2008
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
    BMC pharmacology, 2009, Apr-15, Volume: 9

    Topics: Animals; Atorvastatin; Benzenesulfonates; Cystadenoma; Disease Models, Animal; Doxycycline; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Heptanoic Acids; Immunosuppressive Agents; Interferon-gamma; Kidney Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neoplasms, Experimental; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sirolimus; Sorafenib; Survival Analysis; Treatment Outcome; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Burden; Tumor Suppressor Proteins

2009
Effects of antalarmin and nadolol on the relationship between social stress and pulmonary metastasis development in male OF1 mice.
    Behavioural brain research, 2009, Dec-14, Volume: 205, Issue:1

    Topics: Adrenergic beta-Antagonists; Aggression; Animals; Central Nervous System Agents; Corticosterone; Interferon-gamma; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Nadolol; Neoplasms, Experimental; Pyrimidines; Pyrroles; Random Allocation; Receptors, Corticotropin-Releasing Hormone; Social Behavior; Stress, Psychological

2009
Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antioxidants; Body Weight; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cisplatin; Drug Synergism; Female; Indoles; Kidney; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Organ Size; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Sunitinib; Tumor Burden; Vascular Endothelial Growth Factor A

2011
HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors.
    Cancer research, 2010, Dec-15, Volume: 70, Issue:24

    Topics: Angiogenesis Inhibitors; Animals; Drug Resistance, Neoplasm; Hepatocyte Growth Factor; Humans; Indoles; Mice; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; NIH 3T3 Cells; Proto-Oncogene Proteins c-met; Pyrroles; Signal Transduction; Sunitinib; Transfection

2010
Effect of sunitinib combined with ionizing radiation on endothelial cells.
    Journal of radiation research, 2011, Volume: 52, Issue:1

    Topics: Animals; Cell Line, Tumor; Cell Survival; Cells, Cultured; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Endothelial Cells; Humans; Indoles; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Pyrroles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Sunitinib; Treatment Outcome

2011
Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy.
    International journal of cancer, 2012, Apr-15, Volume: 130, Issue:8

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carcinoembryonic Antigen; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Flow Cytometry; Humans; Immune System; Indoles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Experimental; Pyrroles; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Sunitinib; T-Lymphocytes, Regulatory; Treatment Outcome

2012
Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer.
    Biochemical pharmacology, 2011, Nov-01, Volume: 82, Issue:9

    Topics: Animals; Antineoplastic Agents; Atorvastatin; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Hypolipidemic Agents; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 6; Neoplasms, Experimental; NF-kappa B; Pyrroles; ras Proteins; Receptor, ErbB-2; rhoA GTP-Binding Protein; Terpenes

2011
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors.
    Oncology reports, 2011, Volume: 26, Issue:5

    Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Cell Growth Processes; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; HEK293 Cells; Humans; Indoles; Mice; Mice, Inbred NOD; Mice, SCID; Microvessels; Neoplasms, Experimental; Neovascularization, Pathologic; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrroles; Random Allocation; Sunitinib; Xenograft Model Antitumor Assays

2011
Investigations regarding the utility of prodigiosenes to treat leukemia.
    Organic & biomolecular chemistry, 2013, Jan-07, Volume: 11, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Leukemia; Molecular Structure; Neoplasms, Experimental; Prodigiosin; Pyrroles; Structure-Activity Relationship; Zebrafish

2013
Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells.
    Advanced materials (Deerfield Beach, Fla.), 2013, Feb-06, Volume: 25, Issue:5

    Topics: HeLa Cells; Humans; Hyperthermia, Induced; Materials Testing; Nanoparticles; Neoplasms, Experimental; Photosensitizing Agents; Phototherapy; Polymers; Pyrroles; Treatment Outcome

2013
Dose-dependent response of tumor vasculature to radiation therapy in combination with Sunitinib depicted by three-dimensional high-frequency power Doppler ultrasound.
    Angiogenesis, 2013, Volume: 16, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Dose-Response Relationship, Drug; Immunohistochemistry; Indoles; Mice; Neoplasms, Experimental; Pyrroles; Sunitinib; Ultrasonography, Doppler

2013
Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas.
    The American journal of pathology, 2002, Volume: 161, Issue:3

    Topics: Animals; Antineoplastic Agents; Deoxycytidine; Endothelium, Vascular; ErbB Receptors; Gemcitabine; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Paclitaxel; Pyrimidines; Pyrroles; Signal Transduction; Tumor Cells, Cultured

2002
Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Dacarbazine; Disease Models, Animal; Drug Interactions; Glioma; Indoles; Neoplasm Transplantation; Neoplasms, Experimental; Pyrroles; Rats; Rats, Nude; Receptors, Vascular Endothelial Growth Factor; Temozolomide; Tumor Cells, Cultured

2003
SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
    Cancer research, 2003, Jul-15, Volume: 63, Issue:14

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Combined Modality Therapy; Endothelium, Vascular; Glioblastoma; Humans; Indoles; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neovascularization, Pathologic; Pyrroles; Receptor Protein-Tyrosine Kinases; Sunitinib

2003
Importance of vascular endothelial growth factor A in the progression of experimental neuroblastoma.
    Angiogenesis, 2002, Volume: 5, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Cell Division; Endothelial Growth Factors; Female; Humans; Indoles; Male; Mice; Mice, Nude; Neoplasms, Experimental; Neuroblastoma; Protein-Tyrosine Kinases; Pyrroles; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2002
[Studies on a combined effect of the antibiotic 6270 and certain synthetic preparations with antineoplastic action on the growth of experimental tumors].
    Antibiotiki, 1961, Volume: 6

    Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antineoplastic Agents; Neoplasms, Experimental; Pyrroles

1961
[ADDITIONAL CLASSES OF COMPOUNDS INHIBITING TUMORS. I. CYTOSTATIC EFFECTS OF N- AND S-HYDROXYMETHYL COMPOUNDS].
    Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1963, Volume: 334

    Topics: Amides; Animals; Antineoplastic Agents; Benzimidazoles; Carbohydrate Metabolism; Carcinoma, Ehrlich Tumor; Cytostatic Agents; Formaldehyde; Hydantoins; Imidazoles; Isonicotinic Acids; Mice; Morpholines; Neoplasms, Experimental; Niacin; Niacinamide; Piperazines; Piperidines; Pyrroles; Research; Urea

1963
THE HUMAN TUMOR-EGG HOST SYSTEM. III. TUMOR-INHIBITORY PROPERTIES OF TENUAZONIE ACID.
    Cancer research, 1964, Volume: 24

    Topics: Adenocarcinoma; Antineoplastic Agents; Aspergillus; Azaserine; Carcinoma, Bronchogenic; Chick Embryo; Glycine; Mercaptopurine; Neoplasms; Neoplasms, Experimental; Puromycin; Pyrroles; Research; Saccharomyces; Tissue Culture Techniques; Triethylenemelamine

1964
[Studies on the effect of 6 alkaloids related to 1-methylpyrrolizidine on the growth of hepatoma and of certain other transplanted tumors in animals].
    Biulleten' eksperimental'noi biologii i meditsiny, 1959, Volume: 48

    Topics: Alkaloids; Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Liver Neoplasms, Experimental; Neoplasm Transplantation; Neoplasms, Experimental; Pyrroles

1959
Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008.
    Oncology research, 2003, Volume: 14, Issue:1

    Topics: Acetanilides; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Transformed; Disease Models, Animal; Drug Resistance, Multiple; Humans; Mice; Neoplasms, Experimental; Pyrroles; Quinolines

2003
Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238.
    International journal of cancer, 2005, May-01, Volume: 114, Issue:5

    Topics: Animals; Antineoplastic Agents; Body Weight; Doxorubicin; Humans; Kinetics; Leukocytes; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Peptides; Pyrroles; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Time Factors

2005
Angiogenesis inhibitor Z24 induces endothelial cell apoptosis and suppresses tumor growth and metastasis.
    Journal of pharmacological sciences, 2005, Volume: 97, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Colonic Neoplasms; Endothelium, Vascular; Humans; Lung Neoplasms; Male; Mesylates; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Pyrroles; Transplantation, Heterologous

2005
Medicinal chemistry approaches to target the kinase activity of IGF-1R.
    IDrugs : the investigational drugs journal, 2006, Volume: 9, Issue:6

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Benzimidazoles; Drug Evaluation, Preclinical; Humans; Neoplasms, Experimental; Podophyllotoxin; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Pyridones; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction; Tyrphostins

2006
[Effect of angiogenesis inhibitor SU6668 on the growth and metastasis of gastric cancer in SCID mice].
    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2006, Volume: 9, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Drug Synergism; Fluorouracil; Humans; Indoles; Liver Neoplasms; Male; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Oxindoles; Propionates; Pyrroles; Stomach Neoplasms

2006
Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119).
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:1

    Topics: Animals; Anthramycin; Antibiotics, Antineoplastic; Benzodiazepines; Cell Proliferation; Chromatography, High Pressure Liquid; Gene Expression Profiling; Humans; Mass Spectrometry; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pyrroles; Transplantation, Heterologous

2007
Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    La Radiologia medica, 2007, Volume: 112, Issue:3

    Topics: Adenocarcinoma; Albumins; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Colonic Neoplasms; Contrast Media; Gadolinium DTPA; Indoles; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Microcirculation; Neoplasms, Experimental; Organometallic Compounds; Oxindoles; Propionates; Protein-Tyrosine Kinases; Pyrroles; Rats; Tamoxifen

2007
Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines.
    Bioorganic & medicinal chemistry, 2007, Jul-01, Volume: 15, Issue:13

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Heterocyclic Compounds, 2-Ring; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pyrroles; Structure-Activity Relationship

2007
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Jan-01, Volume: 14, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Endothelial Cells; Female; Fluorescent Antibody Technique; Humans; Indoles; Lenalidomide; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Pyrroles; Rats; Sunitinib; Thalidomide; Xenograft Model Antitumor Assays

2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program.
    Pediatric blood & cancer, 2008, Volume: 51, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Child; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indoles; Mice; Neoplasms, Experimental; Pyrroles; Sunitinib; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays

2008
Activity of bis-carbamoyloxymethyl derivatives of pyrroles and pyrrolizines against human tumor xenografts in nude mice.
    Cancer research, 1982, Volume: 42, Issue:6

    Topics: Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Small Cell; Cell Line; Colonic Neoplasms; Drug Evaluation, Preclinical; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Pyrroles; Pyrrolidines; Transplantation, Heterologous

1982
Synthesis and murine antineoplastic activity of bis[(carbamoyloxy)methyl] derivatives of pyrrolo[2,1-a]isoquinoline.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbamates; Chemical Phenomena; Chemistry; Isoquinolines; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Neoplasms, Experimental; Pyrroles; Spectrophotometry, Infrared; Structure-Activity Relationship; Transplantation, Heterologous

1984
Vinylogous carbinolamine tumor inhibitors. 8. Activity of bis(acyloxymethyl) derivatives of pyrroles and pyrrolizines against a panel of murine leukemias and solid tumors.
    Cancer treatment reports, 1982, Volume: 66, Issue:1

    Topics: Animals; Drug Evaluation, Preclinical; Leukemia, Experimental; Male; Mice; Neoplasms, Experimental; Pyrroles; Pyrrolidines; Structure-Activity Relationship

1982
[Studies on tenuazonic acid analogs. IV. Preparation of condensation products of 3-acetyltetramanilide with substituted benzaldehydes and their antitumor activities (author's transl)].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1981, Volume: 101, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Benzaldehydes; Chemical Phenomena; Chemistry, Physical; Mice; Neoplasms, Experimental; Pyrroles; Tenuazonic Acid

1981
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.
    Cancer research, 1999, Jan-01, Volume: 59, Issue:1

    Topics: 3T3 Cells; Animals; Catalysis; Cell Division; Endothelium, Vascular; Enzyme Inhibitors; Glioma; Humans; Indoles; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Protein-Tyrosine Kinases; Pyrroles; Rats; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Tumor Cells, Cultured

1999
Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506.
    Bioorganic & medicinal chemistry letters, 1999, May-03, Volume: 9, Issue:9

    Topics: Animals; Antineoplastic Agents; Carbazoles; DNA Topoisomerases, Type I; Enzyme Inhibitors; Glucosides; Humans; Indoles; Inhibitory Concentration 50; Kinetics; Mice; Models, Chemical; Neoplasms, Experimental; Pyrroles; Topoisomerase I Inhibitors; Tumor Cells, Cultured

1999
Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel.
    Cancer research, 1999, Aug-15, Volume: 59, Issue:16

    Topics: Animals; Antineoplastic Agents, Alkylating; Benzimidazoles; DNA-Binding Proteins; DNA, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pyrroles; Transplantation, Heterologous; Tumor Cells, Cultured

1999
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
    Cancer research, 2000, Aug-01, Volume: 60, Issue:15

    Topics: 3T3 Cells; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Division; Crystallography, X-Ray; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Indoles; Kinetics; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Oxindoles; Propionates; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor beta; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous; Tumor Cells, Cultured

2000
Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing beta-(5',6',7'-trimethoxy-2'-indolyl)acryloyl group.
    Bioorganic & medicinal chemistry, 2000, Volume: 8, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Duocarmycins; HeLa Cells; Humans; Indoles; Inhibitory Concentration 50; Leukocyte Count; Male; Mice; Neoplasms, Experimental; Platelet Count; Pyrroles; Pyrrolidinones; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured

2000
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; Binding, Competitive; Cell Division; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasms, Experimental; Pancreatic Neoplasms; Pyrroles; Receptors, Somatostatin; RNA, Messenger; Survival Analysis; Time Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001
Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238.
    International journal of oncology, 2002, Volume: 20, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cytotoxins; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Octreotide; Prostatic Neoplasms; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Treatment Outcome; Tumor Cells, Cultured

2002
SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Blood Vessels; Cell Division; Dose-Response Relationship, Drug; Humans; Indoles; Kinetics; Mice; Mice, Nude; Neoplasms, Experimental; Oxindoles; Propionates; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor beta; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2002
Nitropyrrole radiosensitizers: structure function relationships.
    The British journal of cancer. Supplement, 1978, Volume: 3

    Topics: Animals; Cell Survival; In Vitro Techniques; Mice; Neoplasms, Experimental; Oxygen Consumption; Pyrroles; Radiation-Sensitizing Agents; Structure-Activity Relationship

1978
Effects of some pyrrolic and dihydropyrrolizine esters on mouse skin: a preliminary study.
    Tumori, 1979, Jun-30, Volume: 65, Issue:3

    Topics: Alkylating Agents; Animals; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Pyrroles; Pyrrolizidine Alkaloids; Skin Neoplasms; Structure-Activity Relationship

1979
[Effect of a synthetic derivative of verrucarine E and endoxan Guerin's tumor in rats].
    Roczniki Akademii Medycznej im. Juliana Marchlewskiego w Bialymstoku, 1975, Volume: 20

    Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cyclophosphamide; Male; Neoplasms, Experimental; Pyrroles; Rats; Syndrome

1975
Enzymes metabolizing delta1-pyrroline-5-carboxylate in rat tissues.
    The Biochemical journal, 1977, Jul-15, Volume: 166, Issue:1

    Topics: Animals; Fetus; Neoplasms, Experimental; Oxidoreductases; Proline; Pyrroles; Pyrroline Carboxylate Reductases; Rats; Stereoisomerism; Temperature

1977
Subacute toxicity of a halogenated pyrrole hydroxymethylglutaryl-coenzyme A reductase inhibitor in Wistar rats.
    Toxicologic pathology, 1992, Volume: 20, Issue:4

    Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratosis; Liver; Male; Mevalonic Acid; Necrosis; Neoplasms, Experimental; Organ Size; Pyrroles; Rats; Rats, Wistar; Stomach; Stomach Diseases

1992
Photophysical properties and photodynamic activity in vivo of some tetrapyrroles.
    Biophysical chemistry, 1990, Volume: 35, Issue:2-3

    Topics: Animals; Chemical Phenomena; Chemistry, Physical; Female; Fluorescence; Luminescent Measurements; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Neoplasms, Experimental; Photochemistry; Photochemotherapy; Pyrroles; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet

1990
Inhibition of ribosomal RNA maturation in Novikoff hepatoma cells by toyocamycin, tubercidin, and 6-thioguanosine.
    Cancer research, 1974, Volume: 34, Issue:3

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Guanosine; Liver Neoplasms; Mercaptopurine; Methionine; Neoplasms, Experimental; Nitriles; Pyrimidines; Pyrroles; Ribonucleosides; RNA, Neoplasm; RNA, Ribosomal; Tritium; Uridine

1974
Interference with nucleoside transport in mouse lymphoma cells proliferating in culture.
    Cancer research, 1972, Volume: 32, Issue:10

    Topics: Adenosine; Animals; Ascitic Fluid; Aza Compounds; Biological Transport; Bromodeoxyuridine; Carbon Isotopes; Cell Division; Cell-Free System; Cells, Cultured; Guanosine; Inosine; Lymphoma; Male; Mercaptopurine; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pyrazoles; Pyrimidinones; Pyrroles; Ribonucleosides; Thymidine; Time Factors; Transplantation, Homologous

1972
Antitumor, cytotoxic, and antibacterial activities of tenuazonic acid and congeneric tetramic acids.
    Journal of medicinal chemistry, 1965, Volume: 8, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bacillus megaterium; Chemistry, Pharmaceutical; Chick Embryo; Culture Techniques; Neoplasms, Experimental; Pyrroles

1965
[Research on compounds with antineoplastic activity. 47. 1-(2,5-Dimethoxyphenyl)pyrrole derivatives: synthesis and cytostatic activity].
    Il Farmaco; edizione scientifica, 1972, Volume: 27, Issue:10

    Topics: Aldehydes; Antineoplastic Agents; Carboxylic Acids; Culture Media; Magnetic Resonance Spectroscopy; Neoplasms, Experimental; Pyrroles; Spectrophotometry, Infrared; Structure-Activity Relationship

1972
[Activation of protective reactions of the organism in malignant growths].
    Zhurnal eksperimental'noi i klinicheskoi meditsiny, 1968, Volume: 8, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Benzimidazoles; Drug Synergism; Immunity, Active; Neoplasms, Experimental; Parasympatholytics; Pigments, Biological; Prodigiosin; Pyrroles; Rabbits; Rats; Zymosan

1968